• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home The Scan by 2 Minute Medicine®

New York confirms first locally acquired chikungunya case in six years

byDeepti Shroff
October 24, 2025
in The Scan by 2 Minute Medicine®
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. New York has confirmed the first locally transmitted chikungunya infection in the United States since 2019.
2. Climate shifts and expanding Aedes mosquito habitats are driving a steady rise in tropical virus exposure across temperate regions.

Public health officials in New York have confirmed that a Nassau County resident tested positive for chikungunya virus, marking the first locally transmitted case in the United States in six years. The infection was identified through routine surveillance, and health authorities verified that the patient had not recently traveled abroad. Chikungunya is transmitted by Aedes albopictus mosquitoes and causes fever, rash, and severe joint pain that can last weeks or even months. The illness rarely leads to death, but post-viral arthritis can persist long after recovery. Following the diagnosis, New York State launched targeted mosquito control operations and intensified vector surveillance across Long Island and nearby boroughs. So far, no additional local cases have been detected, though entomologists have collected numerous Aedes larvae from standing water sites. Globally, chikungunya activity has surged in 2025, with more than 440,000 confirmed cases reported across India, Brazil, and Southeast Asia. Rising global temperatures are lengthening mosquito breeding seasons, extending transmission windows well beyond tropical regions. Experts say this local case is not an isolated anomaly but a preview of what to expect as climate conditions shift. The Centers for Disease Control and Prevention is urging clinicians nationwide to consider arboviral testing for febrile illness even without travel history. Infectious disease specialists are watching closely to see whether clusters emerge over the coming months. The case underscores the fragility of vector surveillance systems, which rely on steady funding and rapid response. For primary care and urgent care physicians, chikungunya should now sit beside dengue and Zika in differential diagnoses for summer fevers. The event also highlights the value of community education, as early reporting and environmental cleanup remain the most effective prevention tools. While this single case poses little immediate risk, it signals that arboviral boundaries are already blurring. The story of chikungunya in New York may foreshadow the next phase of vector-borne disease in North America.

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

World Health Organization warns that one in six infections now antibiotic resistant

The Scan by 2 Minute Medicine®: FDA clears Alzheimer’s blood test, WHO warns of antibiotic resistance, New York confirms chikungunya case, and CDC layoffs raise concern

Sanofi wins approval for first Bruton’s tyrosine kinase inhibitor in immune thrombocytopenia

Tags: arthritisCDCchikungunyainfectioninfectious diseasemosquitovirusZika
Previous Post

Smartphone-Based Muscle Relaxation for Migraine in the Emergency Department

RelatedReports

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription
The Scan by 2 Minute Medicine®

World Health Organization warns that one in six infections now antibiotic resistant

October 23, 2025
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
Infectious Disease

The Scan by 2 Minute Medicine®: FDA clears Alzheimer’s blood test, WHO warns of antibiotic resistance, New York confirms chikungunya case, and CDC layoffs raise concern

October 21, 2025
Long-term dual antiplatelet therapy does not increase mortality risk
Hematology

Sanofi wins approval for first Bruton’s tyrosine kinase inhibitor in immune thrombocytopenia

September 9, 2025
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Fall boosters, mosquitoes, skin awareness, and Hollywood healing

August 28, 2025

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • New York confirms first locally acquired chikungunya case in six years
  • Smartphone-Based Muscle Relaxation for Migraine in the Emergency Department
  • World Health Organization warns that one in six infections now antibiotic resistant
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.